Flipo R M, Deprez X, Fardellone P, Duquesnoy B, Delcambre B
Service de Rhumatologie, Centre André Verhaeghe, Hôpital B, Lille.
Rev Rhum Ed Fr. 1993 Apr;60(4):269-73.
Although studies of patients with rheumatoid arthritis have found no increases in overall cancer rates, significant elevations in rates of lymphoma and myeloma have been reported, suggesting a causal relationship between autoimmune disorders and lymphoid malignancies. Nevertheless, only 22 cases of concomitant rheumatoid arthritis and multiple myeloma were identified during a retrospective national multicenter study carried out in France. Neither disease exhibited unusual features. In every case, rheumatoid arthritis preceded multiple myeloma. Monoclonal gammopathy preceded multiple myeloma in two patients, by 3 and 7 years respectively. No patient had amyloid arthritis. Analysis of data from the cancer registry of the Somme district in northern France did not suggest a significantly increased risk of multiple myeloma in rheumatoid arthritis patients (relative risk 2.3). Use of interferon alpha to treat myeloma has been reported to exacerbate concomitant autoimmune disorders.
尽管对类风湿性关节炎患者的研究未发现总体癌症发病率增加,但有报告称淋巴瘤和骨髓瘤的发病率显著升高,这表明自身免疫性疾病与淋巴系统恶性肿瘤之间存在因果关系。然而,在法国进行的一项全国性回顾性多中心研究中,仅发现22例类风湿性关节炎合并多发性骨髓瘤的病例。两种疾病均未表现出异常特征。在每一例中,类风湿性关节炎均先于多发性骨髓瘤出现。两名患者分别在3年和7年前出现单克隆丙种球蛋白病,之后才发生多发性骨髓瘤。无一例患者患有淀粉样关节炎。对法国北部索姆地区癌症登记处的数据进行分析,未发现类风湿性关节炎患者患多发性骨髓瘤的风险显著增加(相对风险为2.3)。据报道,使用干扰素α治疗骨髓瘤会加剧并发的自身免疫性疾病。